Weight Management

Weight Loss Obesity Medications Dieting Weight Loss Drugs Caloric Intake Obesity Treatment Medication Weight Loss Treatments Lifestyle Changes

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Full results are slated for presentation at the American Diabetes Association meeting in June.

British Heart Foundation Warns on Salt and Sugar in Gut-Friendly Foods

Magnesium Supplement Guidance Stresses Caution on Dose and Diarrhea Risk

UK Fish-and-Chip Slump Leaves Farmers With Unsold Potatoes

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

Novo Nordisk Extends Weight‑Loss Lead as Amgen’s Once‑Monthly MariTide Reaches Phase 3

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

Oprah Showcases Sleeker Look at Paris Fashion Week After GLP-1-Aided Weight Loss

New Studies Refine GLP-1 Picture: Weight Rebounds After Stopping, With Hints of Lower Addiction Risk

Mama June Says Undiagnosed Illness Could Immobilize Her

After Stopping GLP-1 Weight-Loss Drugs, Most Lost Weight Returns Within a Year, Analysis Finds

Eli Lilly Unveils Employer Connect, Offering Zepbound to Employers at a Uniform $449 Net Price

Patrick Romer Says Weight Rebounds After Dschungelcamp, Back Up to 89 Kilograms

Claudia Oshry Alleges New RHONY Hire Hailey Glassman Sent Years of Body-Shaming DMs

German Endocrinologist Calls for Statutory Coverage of Weight-Loss Injections as Illegal Procurement Rises

Two-Day Oatmeal Regimen Cuts LDL Cholesterol 10% in Small RCT

TikTok Doctor’s Warm-Water Advice for Mornings Spreads in UK Tabloids

Novo Nordisk Slumps on Weak 2026 Outlook as GLP-1 Pill Uptake Builds

Finishing Meals Three Hours Before Bed Tied to Better Heart and Metabolic Markers in Small Trial

Eating Earlier and Extending Overnight Fasts Show Short-Term Heart and Metabolic Gains